Larry Zaslow is a Senior Executive with over 35 years of leadership experience in life science companies, consultancies and investment banking. Larry co-founded BioTheryX, Inc, a privately held, clinical stage targeted protein degradation company. During his tenure at BioTheryX Mr. Zaslow had primary responsibility for critical areas including strategic and operational planning, capital raising, financial planning/budget, corporate and business development, negotiation of licensing deals, investor and public relations. He helped position BioTheryX for its recent $100 million crossover round of financing and assembled a world class Scientific Advisory Board, including a Nobel Laureate. Mr. Zaslow was also a founding managing director of Amphion PLC, where he engaged in the formation, financing, management and development of life science and technology companies seeking to commercialize their intellectual property. He earned his BA in Economics from Brandeis University, and his MBA in Finance from the Columbia Business School.